Skip to main navigation
Monte Rosa Therapeutics
  • News
  • Presentations
  • Contact
  • Search
  • Science
  • Pipeline
  • About
  • Careers
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Our Team
      • Committee Composition
    • Financials & Filings
      • SEC Filings
    • IR Resources
      • FAQs
      • Contact IR
      • Email Alerts
  • Science
  • Pipeline
  • About
  • Careers
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Our Team
      • Committee Composition
    • Financials & Filings
      • SEC Filings
    • IR Resources
      • FAQs
      • Contact IR
      • Email Alerts
  • News
  • Presentations
  • Contact
  • Search

SEC Filing Details

Document Details

Form
4
Filing Date
Jan 5, 2026
Document Date
Jan 2, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Monte Rosa Therapeutics
Issuer
MONTE ROSA THERAPEUTICS, INC.
Filer
JANKU FILIP

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Monte Rosa Therapeutics
  • News
  • Presentations
  • Contact
  • Search
  • Science
  • Pipeline
  • About
  • Careers
  • Investors
© 2026 Monte Rosa Therapeutics All Rights Reserved
privacy policy
terms of use